Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-09-20 Sale | 2024-09-24 4:01 pm | Foghorn Therapeutics Inc. | FHTX | Costa Carlos Chief People Officer | 36,613 | $10.04 | $367,706 | 80,435 (Direct) | View |
| 2024-09-18 Sale | 2024-09-20 4:00 pm | Foghorn Therapeutics Inc. | FHTX | Costa Carlos Chief People Officer | 11,574 | $10.05 | $116,319 | 76,402 (Direct) | View |
| 2024-09-16 Sale | 2024-09-18 4:01 pm | Foghorn Therapeutics Inc. | FHTX | Costa Carlos Chief People Officer | 10,672 | $10.04 | $107,131 | 186,224 (Direct) | View |
| 2024-09-09 Sale | 2024-09-11 4:00 pm | Foghorn Therapeutics Inc. | FHTX | Bellon Steven F. Chief Scientific Officer | 20,000 | $9.5 | $190,000 | 101,957 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-02-05 Option Award | 2026-02-06 4:01 pm | N/A 2036-02-04 | Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer | 1,075,000 | $5.23 | 1,075,000 (Direct) | View |
| 2026-01-30 Option Award | 2026-02-02 4:04 pm | N/A 2036-01-29 | Foghorn Therapeutics Inc. | FHTX | Costa Carlos Chief People Officer | 230,000 | $5.71 | 230,000 (Direct) | View |
| 2026-01-30 Option Award | 2026-02-02 4:03 pm | N/A 2036-01-29 | Foghorn Therapeutics Inc. | FHTX | LaCascia Michael Chief Legal Officer | 295,000 | $5.71 | 295,000 (Direct) | View |
| 2026-01-30 Option Award | 2026-02-02 4:03 pm | N/A 2036-01-29 | Foghorn Therapeutics Inc. | FHTX | Cardama Alfonso Quintas Chief Medical Officer | 300,000 | $5.71 | 300,000 (Direct) | View |
| 2026-01-30 Option Award | 2026-02-02 4:02 pm | N/A 2036-01-29 | Foghorn Therapeutics Inc. | FHTX | Rivkin Anna Chief Business Officer | 165,000 | $5.71 | 165,000 (Direct) | View |
| 2026-01-30 Option Award | 2026-02-02 4:01 pm | N/A 2036-01-29 | Foghorn Therapeutics Inc. | FHTX | Bellon Steven F. Chief Scientific Officer | 300,000 | $5.71 | 300,000 (Direct) | View |
| 2026-01-13 Option Award | 2026-01-15 5:00 pm | 2026-01-13 2046-01-13 | Foghorn Therapeutics Inc. | FHTX | Flagship Pioneering LLC Flagship Pioneering Fund VII General Partner LLC Flagship Pioneering Fund VII L.P. Flagship Pioneering Special Opportunities Fund II General Partner LLC Flagship Pioneering Special Opportunities Fund II L.P. Flagship Ventures Fund V General Partner LLC Flagship Ventures Fund V L.P. Flagship Ventures Opportunities Fund I General Partner LLC Flagship Ventures Opportunities Fund I L.P. AFEYAN NOUBAR Director 10% Owner | 2,235,468 | $6.7099 | 4,470,936 (Indirect) | View |
| 2026-01-13 Option Award | 2026-01-15 5:00 pm | 2026-01-13 2027-06-30 | Foghorn Therapeutics Inc. | FHTX | Flagship Pioneering LLC Flagship Pioneering Fund VII General Partner LLC Flagship Pioneering Fund VII L.P. Flagship Pioneering Special Opportunities Fund II General Partner LLC Flagship Pioneering Special Opportunities Fund II L.P. Flagship Ventures Fund V General Partner LLC Flagship Ventures Fund V L.P. Flagship Ventures Opportunities Fund I General Partner LLC Flagship Ventures Opportunities Fund I L.P. AFEYAN NOUBAR Director 10% Owner | 2,235,468 | $0 | 4,470,936 (Indirect) | View |
| 2025-06-17 Option Award | 2025-06-17 4:29 pm | 2026-06-17 2035-06-16 | Foghorn Therapeutics Inc. | FHTX | SMITH IAN F Director | 25,000 | $4.79 | 25,000 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-17 4:29 pm | 2026-06-17 2035-06-16 | Foghorn Therapeutics Inc. | FHTX | PARSHALL B LYNNE Director | 25,000 | $4.79 | 25,000 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-17 4:28 pm | 2026-06-17 2035-06-16 | Foghorn Therapeutics Inc. | FHTX | Mendelsohn Michael Director | 25,000 | $4.79 | 25,000 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-17 4:28 pm | 2026-06-17 2035-06-16 | Foghorn Therapeutics Inc. | FHTX | Lynch Thomas J. Jr. Director | 25,000 | $4.79 | 25,000 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-17 4:27 pm | 2026-06-17 2035-06-16 | Foghorn Therapeutics Inc. | FHTX | GILL SIMBA Director | 25,000 | $4.79 | 25,000 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-17 4:26 pm | 2026-06-17 2035-06-16 | Foghorn Therapeutics Inc. | FHTX | Biller Scott Director | 25,000 | $4.79 | 25,000 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-17 4:25 pm | 2026-06-17 2035-06-16 | Foghorn Therapeutics Inc. | FHTX | Cole Douglas G. Director | 25,000 | $4.79 | 25,000 (Direct) | View |
| 2025-05-01 Option Award | 2025-05-02 4:04 pm | N/A 2035-04-30 | Foghorn Therapeutics Inc. | FHTX | Gallagher Neil Director | 50,000 | $4.16 | 50,000 (Direct) | View |
| 2025-05-01 Option Award | 2025-05-02 4:03 pm | N/A 2035-04-30 | Foghorn Therapeutics Inc. | FHTX | Duty Stuart Director | 50,000 | $4.16 | 50,000 (Direct) | View |
| 2025-04-25 Gift | 2025-04-28 4:01 pm | N/A N/A | Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer | 300,000 | $0 | 511,704 (Indirect) | View |
| 2025-04-09 Gift | 2025-04-10 4:01 pm | N/A N/A | Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer | 197,906 | $0 | 511,704 (Indirect) | View |
| 2025-01-22 Option Award | 2025-01-24 4:16 pm | N/A 2035-01-21 | Foghorn Therapeutics Inc. | FHTX | Cardama Alfonso Quintas Chief Medical Officer | 125,000 | $4.37 | 125,000 (Direct) | View |
| 2025-01-22 Option Award | 2025-01-24 4:15 pm | N/A 2035-01-21 | Foghorn Therapeutics Inc. | FHTX | Humer Kristian Chief Financial Officer | 120,000 | $4.37 | 120,000 (Direct) | View |
| 2025-01-22 Option Award | 2025-01-24 4:13 pm | N/A 2035-01-21 | Foghorn Therapeutics Inc. | FHTX | Costa Carlos Chief People Officer | 115,000 | $4.37 | 115,000 (Direct) | View |
| 2025-01-22 Option Award | 2025-01-24 4:11 pm | N/A 2035-01-21 | Foghorn Therapeutics Inc. | FHTX | Rivkin Anna Chief Business Officer | 50,000 | $4.37 | 50,000 (Direct) | View |
| 2025-01-22 Option Award | 2025-01-24 4:10 pm | N/A 2035-01-21 | Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer | 400,000 | $4.37 | 400,000 (Direct) | View |
| 2025-01-22 Option Award | 2025-01-24 4:09 pm | N/A 2035-01-21 | Foghorn Therapeutics Inc. | FHTX | Bellon Steven F. Chief Scientific Officer | 140,000 | $4.37 | 140,000 (Direct) | View |
| 2025-01-22 Option Award | 2025-01-24 4:06 pm | N/A 2035-01-21 | Foghorn Therapeutics Inc. | FHTX | LaCascia Michael Chief Legal Officer | 126,000 | $4.37 | 126,000 (Direct) | View |
| 2024-09-20 Exercise | 2024-09-24 4:01 pm | N/A N/A | Foghorn Therapeutics Inc. | FHTX | Costa Carlos Chief People Officer | 36,613 | $3.72 | 80,435 (Direct) | View |
| 2024-09-20 Exercise | 2024-09-24 4:01 pm | N/A 2029-02-12 | Foghorn Therapeutics Inc. | FHTX | Costa Carlos Chief People Officer | 36,613 | $0 | 80,435 (Direct) | View |
| 2024-09-18 Exercise | 2024-09-20 4:00 pm | N/A N/A | Foghorn Therapeutics Inc. | FHTX | Costa Carlos Chief People Officer | 11,574 | $3.72 | 76,402 (Direct) | View |
| 2024-09-18 Exercise | 2024-09-20 4:00 pm | N/A 2029-02-12 | Foghorn Therapeutics Inc. | FHTX | Costa Carlos Chief People Officer | 11,574 | $0 | 76,402 (Direct) | View |
| 2024-09-16 Exercise | 2024-09-18 4:01 pm | N/A N/A | Foghorn Therapeutics Inc. | FHTX | Costa Carlos Chief People Officer | 10,672 | $3.72 | 186,224 (Direct) | View |
| 2024-09-16 Exercise | 2024-09-18 4:01 pm | N/A 2029-02-12 | Foghorn Therapeutics Inc. | FHTX | Costa Carlos Chief People Officer | 10,672 | $0 | 186,224 (Direct) | View |
| 2024-09-03 Option Award | 2024-09-04 4:02 pm | N/A 2034-09-03 | Foghorn Therapeutics Inc. | FHTX | Rivkin Anna Chief Business Officer | 190,000 | $7.85 | 190,000 (Direct) | View |
| 2024-06-26 Option Award | 2024-06-28 4:08 pm | 2025-06-26 2034-06-25 | Foghorn Therapeutics Inc. | FHTX | Biller Scott Director | 16,000 | $5.52 | 16,000 (Direct) | View |
| 2024-06-26 Option Award | 2024-06-28 4:07 pm | 2025-06-26 2034-06-25 | Foghorn Therapeutics Inc. | FHTX | Mendelsohn Michael Director | 16,000 | $5.52 | 16,000 (Direct) | View |
| 2024-06-26 Option Award | 2024-06-28 4:06 pm | 2025-06-26 2034-06-25 | Foghorn Therapeutics Inc. | FHTX | SMITH IAN F Director | 16,000 | $5.52 | 16,000 (Direct) | View |
| 2024-06-26 Option Award | 2024-06-28 4:06 pm | 2025-06-26 2034-06-25 | Foghorn Therapeutics Inc. | FHTX | Lynch Thomas J. Jr. Director | 16,000 | $5.52 | 16,000 (Direct) | View |
| 2024-06-26 Option Award | 2024-06-28 4:04 pm | 2025-06-26 2034-06-25 | Foghorn Therapeutics Inc. | FHTX | GILL SIMBA Director | 16,000 | $5.52 | 16,000 (Direct) | View |